Status:
COMPLETED
Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
Breast cancer is the leading type of cancer in women. Although big advance in diagnostics and treatment of early and breast cancer has been made in recent years breast cancer still has a significant m...
Eligibility Criteria
Inclusion
- Women with at least two finished lines of hormonal treatment for advanced breast cancer Tumor markers (CEA. CA15-3) values available at the time of onset and discontinuation of therapy Imaging methods results available at the time of onset and discontinuation of therapy
Exclusion
- None
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT01265654
Start Date
January 1 2011
End Date
November 1 2011
Last Update
November 23 2011
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Benesov U Prahy, Czechia
2
Research Site
Brno, Czechia
3
Research Site
Cheb, Czechia
4
Research Site
Chomutov, Czechia